Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the complete record of transactions filed by Freeman Chris, Directeur Commercial. Insider active across 1 company, notably Guardant Health, Inc.. Cumulatively, 35 disclosures have been published. Split: 0 buy · 5 sells. Total volume traded: €9.4m. History available since 15 June 2022. The latest transaction was filed on 10 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Freeman Chris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Freeman Chris is Director Commercial and Chief Commercial Officer at Guardant Health, Inc. He has 29 filings in total, and in the sampled recent filings the sell volume is EUR 41642, covering the period from 2022-06-17 to 2026-06-16. The most common transaction nature is option exercise.